Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.99 USD | +5.56% |
|
+11.28% | +30.18% |
15/07 | Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating | MT |
01/07 | Core Laboratories Inc.(NYSE:CLB) dropped from Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.18% | 1.08B | |
0.00% | 8.78B | |
-20.42% | 2.61B | |
-21.53% | 2.4B | |
-24.72% | 1.9B | |
-15.72% | 1B | |
-18.71% | 930M | |
-3.32% | 728M | |
-32.02% | 633M | |
-36.58% | 563M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating